Progyny

New York, United States Founded: 2008 • Age: 18 yrs
Fertility benefits management is offered via an appointment booking platform.
Annual revenue $1.2B Latest available
Total funding $24.8M 3 rounds
Employees 680 Tracked headcount
Investors 6 Known backers
Products 3 Services tracked
Competitors 4 Brand Intelligence

About Progyny

Progyny is a company based in New York (United States) founded in 2008. Progyny has raised $24.77 million across 3 funding rounds from investors including Kleiner Perkins, TPG and SR One. The company has 680 employees as of December 31, 2024. Progyny has completed 2 acquisitions, including Apryl and Benefit Bump. Progyny offers products and services including Fertility Benefits, Pregnancy Care, and Menopause Benefits. Progyny operates in a competitive market with competitors including Fertility Authority, MynewMD, EggBanxx and Dominion Gynecology, among others.

  • Headquarter New York, United States
  • Employees 680 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Technology
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Progyny, Inc.
Operational Areas
Technology → Enterprise Software & Productivity Solutions Unlock Sub-Sector Unlock Segment
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $1.17 B (USD)
    7.22
    as on Dec 31, 2024
  • Net Profit
    $54.34 M (USD)
    -12.41
    as on Dec 31, 2024
  • EBITDA
    $70.63 M (USD)
    9.56
    as on Dec 31, 2024
  • Total Equity Funding
    $24.77 M (USD)

    in 3 rounds

  • Latest Funding Round
    $10 M (USD), Series B

    May 02, 2017

  • Investors
  • Employee Count
    680

    as on Dec 31, 2024

  • Investments & Acquisitions
    Apryl

    & 1 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Progyny

Progyny is a publicly listed company on the NASDAQ with ticker symbol PGNY in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: PGNY · Sector: Commercial services · USA

Products & Services of Progyny

Progyny offers a comprehensive portfolio of products and services, including Fertility Benefits, Pregnancy Care, and Menopause Benefits.

Product name locked
Category locked
Primary

Supports fertility treatments and family building for employees.

Product name locked
Category locked
Locked

Offers pregnancy and postpartum support programs.

Product name locked
Category locked
Locked

Provides care for menopause and midlife health needs.

People of Progyny

Headcount 50-200
Employee Profiles 172
Employee Profiles
People
Cary Wallin
Vice President, Business Development
People
Lou Amar
Marketing Associate
People
Anyssa Garza
Director, Content Strategy
People
Nyana Dickerson
System Administrator

Unlock access to complete

Funding Insights of Progyny

Progyny has successfully raised a total of $24.77M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $10 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Progyny

Progyny has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, TPG and SR One.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Fund of funds focused on pre-seed and seed-stage companies
Locked Locked Locked
A biotechnology venture capital firm investing in innovative science.
Locked Locked Locked
Venture capital firm investing in early-stage tech startups
Locked Locked Locked
Premium access

Investor details for Progyny

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Progyny

Progyny has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Apryl and Benefit Bump.

Investments
Premium access

Investment portfolio details for Progyny

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Employee benefit services are provided to organizations.
Locked Locked 2020 Locked
Healthcare benefits and consultation services are provided for employees.
Locked Locked 2019 Locked
Premium access

Complete acquisition details for Progyny

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Progyny

Premium access

Detailed financials for Progyny

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Progyny Comparisons

Progyny Primary company
Description
Fertility benefits management is offered via an appointment ...
Location
New York, United States
Founded Year
2008
Annual Revenue
$1.17 B (USD)
Net Profit
$54.34 M (USD)
EBITDA
$70.63 M (USD)
Employees
680
As of 2024
Premium access

Peer comparison for Progyny

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Progyny

Progyny operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fertility Authority, MynewMD, EggBanxx and Dominion Gynecology, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Fertility information and resources are shared online with appointment booking.
Locked Locked Locked
Offers a platform for convenient healthcare appointment booking.
Locked Locked Locked
Offers fertility, family building, and women's health benefits to companies worldwide.
Locked Locked Locked
Offers comprehensive online consultation services with gynecologists for personalized healthcare.
Premium access

Detailed competitors of Progyny

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Progyny

Premium access

Complete news archive for Progyny

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Progyny

Progyny was founded in 2008 and raised its 1st funding round 7 years after it was founded.

Progyny is headquartered in New York, United States. It is registered at New York, New York, United States.

Progyny is a funded company, having raised a total of $24.77M across 3 funding rounds to date.

As of Dec 31, 2024, the latest employee count at Progyny is 680.

Annual revenue of Progyny is $1.17B as on Dec 31, 2024.

Progyny was founded in 2008 in New York, United States, within the healthcare sector focused on fertility services. A platform is provided for users to locate and schedule appointments at fertility clinics. Inclusive benefit plans are made available to employers for addressing employee fertility needs. Operations center on streamlining access to fertility care through technology-driven solutions.

Progyny's top competitors include Fertility Authority, MynewMD and EggBanxx.

Progyny offers Fertility Benefits, Pregnancy Care, and Menopause Benefits.

Yes, Progyny is publicly traded on NASDAQ under the ticker symbol PGNY.

Progyny has made 2 acquisitions, including Apryl, and Benefit Bump.

Progyny has 6 investors. Key investors include Kleiner Perkins, TPG, SR One, Union Grove Venture Partners, and Mellon.

The ticker symbol of Progyny is PGNY on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available